Pilot Study of a an App to Improve Medication Adherence in Breast Cancer Survivors Receiving AIs

NACompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

February 17, 2020

Primary Completion Date

April 29, 2022

Study Completion Date

August 9, 2022

Conditions
Breast CancerDCIS
Interventions
DEVICE

LifeExtend-AI

"LifeExtend-AI (LX-AI) will be piloted by adding AI- specific features to LifeExtend, an already existing healthy lifestyle behavior application produced by LifeOmic. This application includes features for tracking activity, diet, sleep, and body weight, as well as creating to-do lists and participating in closed social networking for support and encouragement. LifeExtend-AI will add features to track AI adherence and patient-reported joint pain, with alerts sent to both the participant and the healthcare team in response to these parameters. In addition, the app contains educational videos and articles, to which articles addressing management of AI- related toxicities (including exercise) will be added."

Trial Locations (1)

46202

Indiana University Melvin & Bren Simon Cancer Center, Indianapolis

All Listed Sponsors
lead

Indiana University

OTHER

NCT04170920 - Pilot Study of a an App to Improve Medication Adherence in Breast Cancer Survivors Receiving AIs | Biotech Hunter | Biotech Hunter